Collecting health data on pregnant cancer patients
Collection of Outcomes Data for Pregnant Patients With Cancer
M.D. Anderson Cancer Center · NCT00507572
This study is collecting health information from pregnant women with cancer to help improve their treatment and care in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT00507572 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather and store treatment and outcomes information for pregnant patients diagnosed with cancer at M. D. Anderson Cancer Center. It involves both prospective and retrospective reviews of medical records to characterize diseases, treatments, and outcomes. The collected data will be organized in a secure repository to facilitate future research and improve patient care for this unique population.
Who should consider this trial
Good fit: Ideal candidates include all pregnant patients with cancer or those who have been pregnant with a cancer diagnosis, regardless of their specific condition.
Not a fit: Patients who are not pregnant or have never been pregnant with cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding and management of cancer in pregnant patients, leading to improved care and outcomes.
How similar studies have performed: While this approach is focused on a specific patient population, similar studies have successfully collected outcomes data in other cancer contexts, indicating potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All pregnant patients with cancer and patients known to have been pregnant with a diagnosis of cancer are eligible, regardless of their diagnosis or treatment plan * Patients may receive prenatal care from any obstetrician, but a consult with Maternal Fetal Medicine is encouraged
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Andrea M Milbourne — M.D. Anderson Cancer Center
- Study coordinator: Andrea Milbourne
- Email: amilbour@mdanderson.org
- Phone: 713-745-6986
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm